KORU Medical Systems Inc KRMD.OQ KRMD.O is expected to show a rise in quarterly revenue when it reports results on August 6 for the period ending June 30 2025
The Mahwah New Jersey-based company is expected to report a 12.2% increase in revenue to $9.46 million from $8.43 million a year ago, according to the mean estimate from 5 analysts, based on LSEG data.
LSEG's mean analyst estimate for KORU Medical Systems Inc is for a loss of 2 cents per share.
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell."
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for KORU Medical Systems Inc is $6.00, about 43.7% above its last closing price of $3.38
Previous quarterly performance (using preferred earnings measure in US dollars).
QUARTER ENDING
STARMINESMARTESTIMATE®
LSEG IBES ESTIMATE
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Mar. 31 2025
-0.03
-0.03
-0.02
Beat
23.1
Dec. 31 2025
-0.03
-0.03
-0.03
Met
2
Sep. 30 2024
-0.03
-0.04
-0.03
Beat
21.1
Jun. 30 2024
-0.05
-0.04
-0.02
Beat
52.4
Mar. 31 2024
-0.04
-0.04
-0.02
Beat
47.4
Dec. 31 2023
-0.05
-0.04
-0.03
Beat
25
Sep. 30 2023
-0.06
-0.05
-0.03
Beat
40
Jun. 30 2023
-0.06
-0.06
-0.05
Beat
11.8
This summary was machine generated August 4 at 22:23 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)